Clinical Efficacy of Vitrectomy on Vitreomacular Traction Syndrome

  Objective  To observe the clinical efficacy of vitrectomy on vitreomacular traction syndrome.

  Methods  The clinical data of 22 evaluable eyes of 22 patients with vitreomacular traction syndrome who were diagnosed by spectral-domain optical coherence tomography (SD-OCT) and underwent vitrectomy from January 2008 to December 2012 were retrospectively analyzed. Patients were followed up for an average of 8 months(1-51 months), and the changes of best corrected visual acuity (BCVA) and retinal thickness of macular fovea were recorded.

  Results  After the treatment, BCVA improved significantly in 12 eyes (54.5%), improved mildly in 6 eyes (27.3%), stabilized in 3 eyes (13.6%), and decreased in 1 eye (4.5%). The proportion of patients with BCVA ≥ 0.3 increased from 13.6% before operation to 59.1% after operation. The mean retinal thicknesses of macular fovea were(545±175)μm preoperatively and (220±105) μm postoperatively, respectively (P < 0.01).

  Conclusion  Vitrectomy is an effective way to improve vision and decrease macular edema in patients with vitreomacular traction syndrome.